Searching map area
Secukinumab
? TBD
Monoclonal antibody against IL-17
Join to rate
Join to rate

Secukinumab, sold under the brand name Cosentyx among others, is a human IgG1κ monoclonal antibody used for the treatment of psoriasis, ankylosing spondylitis, and psoriatic arthritis. It binds to the protein interleukin (IL)-17A and is marketed by Novartis.

Instance of
type of chemical entity
Subclass of
Chemical compound
Wikidata